Guidance on summary reports and issue-related analyses for medical devices: Overview

Guidance on summary reports and issue-related analyses for medical devices: Overview This guidance document was prepared to help medical device manufacturers understand and comply with sections 25, 39 and 61.4 to 61.6 of the Medical Devices Regulations. Two new requirements in the Regulations were added to ensure the continued monitoring of benefits and risks after a product is authorized for sale in Canada. 2024-03-30 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyGuidancesummary reportsissue-related analysesmedical devicesoverviewmedical device manufacturersMedical Devices Regulationssections 2539 and 61.4 to 61.6new requirementsmonitoringbenefits and risksa productauthorized for sale Guidance on summary reports and issue-related analyses for medical devices: OverviewHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/medical-device-reports-analyses-guidance.html Guidance on summary reports and issue-related analyses for medical devices: OverviewHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/rapports-publications/medeffet-canada/instruments-medicaux-rapports-analyses-lignes-directrices.html

This guidance document was prepared to help medical device manufacturers understand and comply with sections 25, 39 and 61.4 to 61.6 of the Medical Devices Regulations. Two new requirements in the Regulations were added to ensure the continued monitoring of benefits and risks after a product is authorized for sale in Canada.

Data and Resources

Similar records